These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 8302851)
21. Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations. Sevanian A; Hwang J; Hodis H; Cazzolato G; Avogaro P; Bittolo-Bon G Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):784-93. PubMed ID: 8640406 [TBL] [Abstract][Full Text] [Related]
22. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. Frei B; Gaziano JM J Lipid Res; 1993 Dec; 34(12):2135-45. PubMed ID: 8301232 [TBL] [Abstract][Full Text] [Related]
23. Antioxidant content in low density lipoprotein and lipoprotein oxidation in vivo and in vitro. Tertov VV; Sobenin IA; Kaplun VV; Orekhov AN Free Radic Res; 1998 Aug; 29(2):165-73. PubMed ID: 9790519 [TBL] [Abstract][Full Text] [Related]
24. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Esterbauer H; Dieber-Rotheneder M; Striegl G; Waeg G Am J Clin Nutr; 1991 Jan; 53(1 Suppl):314S-321S. PubMed ID: 1985404 [TBL] [Abstract][Full Text] [Related]
25. Oxidation of LDL and their subfractions: kinetic aspects and CoQ10 content. Alleva R; Tomasetti M; Bompadre S; Littarru GP Mol Aspects Med; 1997; 18 Suppl():S105-12. PubMed ID: 9266511 [TBL] [Abstract][Full Text] [Related]
26. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. de Graaf J; Hak-Lemmers HL; Hectors MP; Demacker PN; Hendriks JC; Stalenhoef AF Arterioscler Thromb; 1991; 11(2):298-306. PubMed ID: 1998647 [TBL] [Abstract][Full Text] [Related]
27. Mechanisms of lipid peroxidation in human blood plasma: a kinetic approach. Karten B; Beisiegel U; Gercken G; Kontush A Chem Phys Lipids; 1997 Aug; 88(2):83-96. PubMed ID: 9314186 [TBL] [Abstract][Full Text] [Related]
28. The role of copper reduction by alpha-tocopherol in low-density lipoprotein oxidation. Proudfoot JM; Croft KD; Puddey IB; Beilin LJ Free Radic Biol Med; 1997; 23(5):720-8. PubMed ID: 9296448 [TBL] [Abstract][Full Text] [Related]
29. How different constituents of human plasma and low density lipoprotein determine plasma oxidizability by copper. Spranger T; Finckh B; Fingerhut R; Kohlschütter A; Beisiegel U; Kontush A Chem Phys Lipids; 1998 Jan; 91(1):39-52. PubMed ID: 9488998 [TBL] [Abstract][Full Text] [Related]
30. Antioxidants and resistance against oxidation of porcine LDL subfractions. Knipping G; Rotheneder M; Striegl G; Esterbauer H J Lipid Res; 1990 Nov; 31(11):1965-72. PubMed ID: 2086695 [TBL] [Abstract][Full Text] [Related]
31. Comparison of the effects of dietary vitamin E on in vivo and in vitro parameters of lipid peroxidation in the rabbit. Wiseman SA; Van den Boom MA; De Fouw NJ; Wassink MG; Op den Kamp JA; Tijburg LB Free Radic Biol Med; 1995 Nov; 19(5):617-26. PubMed ID: 8529921 [TBL] [Abstract][Full Text] [Related]
32. Contribution of vitamin A to the oxidation resistance of human low density lipoproteins. Livrea MA; Tesoriere L; Bongiorno A; Pintaudi AM; Ciaccio M; Riccio A Free Radic Biol Med; 1995 Mar; 18(3):401-9. PubMed ID: 9101230 [TBL] [Abstract][Full Text] [Related]
33. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Tribble DL; Holl LG; Wood PD; Krauss RM Atherosclerosis; 1992 Apr; 93(3):189-99. PubMed ID: 1590824 [TBL] [Abstract][Full Text] [Related]
34. Alpha-tocopherol as a reductant for Cu(II) in human lipoproteins. Triggering role in the initiation of lipoprotein oxidation. Kontush A; Meyer S; Finckh B; Kohlschütter A; Beisiegel U J Biol Chem; 1996 May; 271(19):11106-12. PubMed ID: 8626654 [TBL] [Abstract][Full Text] [Related]
35. Effect of antioxidants alone and in combination with monounsaturated fatty acid-enriched diets on lipoprotein oxidation. Reaven P; Grasse B; Barnett J Arterioscler Thromb Vasc Biol; 1996 Dec; 16(12):1465-72. PubMed ID: 8977450 [TBL] [Abstract][Full Text] [Related]
36. Whole plasma oxidation assay as a measure of lipoprotein oxidizability. Kontush A; Spranger T; Reich A; Djahansouzi S; Karten B; Braesen JH; Finckh B; Kohlschütter A; Beisiegel U Biofactors; 1997; 6(2):99-109. PubMed ID: 9259991 [TBL] [Abstract][Full Text] [Related]
37. The susceptibility of low-density lipoprotein to in vitro oxidation is increased in hypercholesterolemic patients. Cominacini L; Pastorino AM; Garbin U; Campagnola M; de Santis A; Davoli A; Faccini G; Bertozzo L; Pasini F; Pasini AF Nutrition; 1994; 10(6):527-31. PubMed ID: 7703599 [TBL] [Abstract][Full Text] [Related]
38. Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD. Roob JM; Rabold T; Hayn M; Khoschsorur G; Resch U; Holzer H; Winklhofer-Roob BM Kidney Int Suppl; 2001 Feb; 78():S128-36. PubMed ID: 11168998 [TBL] [Abstract][Full Text] [Related]
39. Reduced susceptibility to oxidation of low-density lipoprotein in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome). Calò L; Sartore G; Bassi A; Basso C; Bertocco S; Marin R; Zambon S; Cantaro S; D'Angelo A; Davis PA; Manzato E; Crepaldi G J Hypertens; 1998 Jul; 16(7):1001-8. PubMed ID: 9794741 [TBL] [Abstract][Full Text] [Related]
40. Distribution of lipid-soluble antioxidants in lipoproteins from healthy subjects. I. Correlation with plasma antioxidant levels and composition of lipoproteins. Perugini C; Bagnati M; Cau C; Bordone R; Zoppis E; Paffoni P; Re R; Albano E; Bellomo G Pharmacol Res; 2000 Jan; 41(1):55-65. PubMed ID: 10600270 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]